Erica Españo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erica Españo has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Jeong-Ki Kim
College of Pharmacy, Korea University, Sejong 30019, Korea
8 shared publications - Bill Thaddeus Padasas
Department of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea
4 shared publications Jeong-Hyun Nam
Department of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea
4 shared publications- Sang-Hyun Kim
College of Pharmacy, Korea University, Sejong 30019, Korea
4 shared publications - Chong-Kil Lee
Department of Pharmaceutics, College of Pharmacy, Chungbuk National University, Cheongju 28644, Korea
3 shared publications - Eun-Jung Song
Nodcure, Inc., 77 Yongbong-ro, Buk-gu, Gwangju 61186, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Elsevier in Journal of Environmental Chemical Engineering
- Vol. 14 (5)
Inhibition of viral infection via adsorption-driven physical sequestration by natural illite: A sustainable, broad-spectrum antiviral material
- 18 August 2026
- Published by Elsevier in Journal of Environmental Chemical Engineering
- Vol. 14 (5)
Open AccessInhibition of viral infection via adsorption-driven physical sequestration by natural illite: A sustainable, broad-spectrum antiviral material
- Open Access
Teicoplanin attenuates RNA virus infection in vitro
Teicoplanin (TP) is a glycopeptide antibiotic used for Gram-positive bacterial infections, and it has been reported to inhibit SARS-CoV-2 and Ebola virus entry through cathepsin inhibition. Given that TP can inhibit viruses belonging to different virus families, we aimed to expand the potential targets of TP to determine whether TP can be developed as a broad-spectrum antiviral agent. Considering the original indication of TP, we first determined the effects of TP against viruses that cause respiratory tract infections and found that TP inhibits enveloped and non-enveloped RNA viruses, namely: human and avian influenza viruses; representative coronaviruses including porcine epidemic diarrhea virus (PEDV), human coronavirus OC43 (HCoV-OC43), and SARS-CoV-2; measles virus; human respiratory syncytial virus A2; and enterovirus 71 (EV-71). Representative flaviviruses, Zika virus (ZIKV) and dengue virus serotype 2 (DENV2), were also susceptible to inhibition by TP. In contrast, TP did not attenuate infection of human adenovirus 5, a non-enveloped DNA virus. Addition of TP at the endocytosis stage but not at the attachment/binding stage of PEDV infection reduced PEDV production in vitro , indicating cathepsin inhibition. Meanwhile, addition of TP during either the attachment/binding or the endocytosis stage of ZIKV infection reduced ZIKV particle production in host cells, and in silico modeling suggested that TP has potential binding pockets in the envelope proteins of ZIKV and DENV2. These results show that TP can be developed as a broad-spectrum antiviral especially against RNA viruses, with potentially different targets in the replication cycle of various viruses.
Open AccessTeicoplanin attenuates RNA virus infection in vitro
Teicoplanin (TP) is a glycopeptide antibiotic used for Gram-positive bacterial infections, and it has been reported to inhibit SARS-CoV-2 and Ebola virus entry through cathepsin inhibition. Given that TP can inhibit viruses belonging to different virus families, we aimed to expand the potential targets of TP to determine whether TP can be developed as a broad-spectrum antiviral agent. Considering the original indication of TP, we first determined the effects of TP against viruses that cause respiratory tract infections and found that TP inhibits enveloped and non-enveloped RNA viruses, namely: human and avian influenza viruses; representative coronaviruses including porcine epidemic diarrhea virus (PEDV), human coronavirus OC43 (HCoV-OC43), and SARS-CoV-2; measles virus; human respiratory syncytial virus A2; and enterovirus 71 (EV-71). Representative flaviviruses, Zika virus (ZIKV) and dengue virus serotype 2 (DENV2), were also susceptible to inhibition by TP. In contrast, TP did not attenuate infection of human adenovirus 5, a non-enveloped DNA virus. Addition of TP at the endocytosis stage but not at the attachment/binding stage of PEDV infection reduced PEDV production in vitro , indicating cathepsin inhibition. Meanwhile, addition of TP during either the attachment/binding or the endocytosis stage of ZIKV infection reduced ZIKV particle production in host cells, and in silico modeling suggested that TP has potential binding pockets in the envelope proteins of ZIKV and DENV2. These results show that TP can be developed as a broad-spectrum antiviral especially against RNA viruses, with potentially different targets in the replication cycle of various viruses.
- Open Access
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (3) , e19
Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines
Kim SH, et al. Immune Netw. 2024 May;24(3):e19. https://doi.org/10.4110/in.2024.24.e19
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (3) , e19
Open AccessInfluenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines
Kim SH, et al. Immune Netw. 2024 May;24(3):e19. https://doi.org/10.4110/in.2024.24.e19
- Open Access
- 1 January 2023
- Published by XMLink in Immune Network
- Vol. 23 (2)
COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
Padasas BT, et al. Immune Netw. 2023 Mar;23(2):e13. https://doi.org/10.4110/in.2023.23.e13
- 1 January 2023
- Published by XMLink in Immune Network
- Vol. 23 (2)
Open AccessCOVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
Padasas BT, et al. Immune Netw. 2023 Mar;23(2):e13. https://doi.org/10.4110/in.2023.23.e13
- Open Access
- 14 December 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-7
Surveillance of avian influenza viruses from 2009 to 2013 in South Korea
Avian influenza viruses (AIVs) are carried by wild migratory waterfowl across migratory flyways. To determine the strains of circulating AIVs that may pose a risk to poultry and humans, regular surveillance studies must be performed. Here, we report the surveillance of circulating AIVs in South Korea during the winter seasons of 2009–2013. A total of 126 AIVs were isolated from 7942 fecal samples from wild migratory birds, with a total isolation rate of 1.59%. H1‒H7 and H9‒H11 hemagglutinin (HA) subtypes, and N1‒N3, N5, and N7‒N9 neuraminidase (NA) subtypes were successfully isolated, with H6 and N2 as the most predominant HA and NA subtypes, respectively. Sequence identity search showed that the HA and NA genes of the isolates were highly similar to those of low-pathogenicity influenza strains from the East Asian-Australasian flyway. No match was found for the HA genes of high-pathogenicity influenza strains. Thus, the AIV strains circulating in wild migratory birds from 2009 to 2013 in South Korea likely had low pathogenicity. Continuous surveillance studies such as this one must be performed to identify potential precursors of influenza viruses that may threaten animal and human health.
- 14 December 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-7
Open AccessSurveillance of avian influenza viruses from 2009 to 2013 in South Korea
Avian influenza viruses (AIVs) are carried by wild migratory waterfowl across migratory flyways. To determine the strains of circulating AIVs that may pose a risk to poultry and humans, regular surveillance studies must be performed. Here, we report the surveillance of circulating AIVs in South Korea during the winter seasons of 2009–2013. A total of 126 AIVs were isolated from 7942 fecal samples from wild migratory birds, with a total isolation rate of 1.59%. H1‒H7 and H9‒H11 hemagglutinin (HA) subtypes, and N1‒N3, N5, and N7‒N9 neuraminidase (NA) subtypes were successfully isolated, with H6 and N2 as the most predominant HA and NA subtypes, respectively. Sequence identity search showed that the HA and NA genes of the isolates were highly similar to those of low-pathogenicity influenza strains from the East Asian-Australasian flyway. No match was found for the HA genes of high-pathogenicity influenza strains. Thus, the AIV strains circulating in wild migratory birds from 2009 to 2013 in South Korea likely had low pathogenicity. Continuous surveillance studies such as this one must be performed to identify potential precursors of influenza viruses that may threaten animal and human health.
- Open Access
- 1 January 2021
- Published by XMLink in Immune Network
- Vol. 21 (1)
COVID-19 Antiviral and Treatment Candidates: Current Status
Españo E, et al. Immune Netw. 2021 Feb;21(1):e7. https://doi.org/10.4110/in.2021.21.e7
- 1 January 2021
- Published by XMLink in Immune Network
- Vol. 21 (1)
Open AccessCOVID-19 Antiviral and Treatment Candidates: Current Status
Españo E, et al. Immune Netw. 2021 Feb;21(1):e7. https://doi.org/10.4110/in.2021.21.e7
- Open Access
- 1 January 2020
- Published by XMLink in Immune Network
- Vol. 20 (4) , e31
Adjuvanticity of Processed Aloe vera gel for Influenza Vaccination in Mice
Song EJ, et al. Immune Netw. 2020 Jul;20(4):e31. https://doi.org/10.4110/in.2020.20.e31
- 1 January 2020
- Published by XMLink in Immune Network
- Vol. 20 (4) , e31
Open AccessAdjuvanticity of Processed Aloe vera gel for Influenza Vaccination in Mice
Song EJ, et al. Immune Netw. 2020 Jul;20(4):e31. https://doi.org/10.4110/in.2020.20.e31
- Open Access
- 7 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Lipophilic statins inhibit Zika virus production in Vero cells
Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family. ZIKV infection has been associated with neurological complications such as microcephaly in newborns and Guillain-Barré syndrome in adults; thus, therapeutic agents are urgently needed. Statins are clinically approved for lowering cholesterol levels to prevent cardiovascular disease but have shown potential as antiviral drugs. In this study, we explored the possibility of utilizing statins as anti-ZIKV drugs. We found that, generally, lipophilic statins (atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, and simvastatin) could reduce ZIKV production in vitro and result in smaller foci of infection. Time-of-drug-addition assay revealed that early treatment with statins is more beneficial than late treatment; however, statins could not completely inhibit the entry stage of ZIKV infection. Furthermore, individual lipophilic statins differed in anti-ZIKV capacity, with fluvastatin being the most efficient at low concentrations. Taken together, this study shows that statins or their derivatives have the potential to be used as anti-ZIKV therapeutic agents.
- 7 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Open AccessLipophilic statins inhibit Zika virus production in Vero cells
Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family. ZIKV infection has been associated with neurological complications such as microcephaly in newborns and Guillain-Barré syndrome in adults; thus, therapeutic agents are urgently needed. Statins are clinically approved for lowering cholesterol levels to prevent cardiovascular disease but have shown potential as antiviral drugs. In this study, we explored the possibility of utilizing statins as anti-ZIKV drugs. We found that, generally, lipophilic statins (atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, and simvastatin) could reduce ZIKV production in vitro and result in smaller foci of infection. Time-of-drug-addition assay revealed that early treatment with statins is more beneficial than late treatment; however, statins could not completely inhibit the entry stage of ZIKV infection. Furthermore, individual lipophilic statins differed in anti-ZIKV capacity, with fluvastatin being the most efficient at low concentrations. Taken together, this study shows that statins or their derivatives have the potential to be used as anti-ZIKV therapeutic agents.
- Open Access
- 1 December 2017
- Published by Microbiology Society in Journal of General Virology
- Vol. 98 (12) , 2950-2954
Molecular and phylogenetic analyses of influenza B viruses isolated from pediatric inpatients in South Korea during the 2011–2012 winter season
Influenza B virus remains a major cause of respiratory diseases worldwide. Because of limited epidemiological and genetic data, the local and global transmission patterns of influenza B virus are not fully understood. Here we report the molecular and phylogenetic characterization of 163 influenza B virus isolates from pediatric inpatients with influenza-like illness in the winter of 2011–2012 in South Korea. Analysis of haemagglutinin and neuraminidase genes of the influenza B isolates revealed that both B/Victoria (62 %) and B/Yamagata lineages (38 %) co-circulated during that influenza season, and a considerable number of the isolates carried several amino acid substitutions in the four major antigenic epitopes of their haemagglutinin protein.
- 1 December 2017
- Published by Microbiology Society in Journal of General Virology
- Vol. 98 (12) , 2950-2954
Open AccessMolecular and phylogenetic analyses of influenza B viruses isolated from pediatric inpatients in South Korea during the 2011–2012 winter season
Influenza B virus remains a major cause of respiratory diseases worldwide. Because of limited epidemiological and genetic data, the local and global transmission patterns of influenza B virus are not fully understood. Here we report the molecular and phylogenetic characterization of 163 influenza B virus isolates from pediatric inpatients with influenza-like illness in the winter of 2011–2012 in South Korea. Analysis of haemagglutinin and neuraminidase genes of the influenza B isolates revealed that both B/Victoria (62 %) and B/Yamagata lineages (38 %) co-circulated during that influenza season, and a considerable number of the isolates carried several amino acid substitutions in the four major antigenic epitopes of their haemagglutinin protein.
- 29 June 2017
- Published by Springer Nature in Archives of Virology
- Vol. 162 (10) , 3017-3024
Rapid virulence shift of an H5N2 avian influenza virus during a single passage in mice
Influenza A viruses must undergo adaptation to acquire virulence in new host species. In mouse models, host adaptation for virulence is generally performed through 5 to 20 lung-to-lung passages. However, highly pathogenic avian influenza viruses (e.g., H5N1 and H7N7 subtypes) have been observed to acquire virulence in mice after only a few in vivo passages. In this study, a low-pathogenic avian influenza H5N2 virus, A/Aquatic Bird/Korea/CN2/2009, which was a prevalent subtype in South Korea in 2009, was serially passaged in mice to evaluate its potential to become highly pathogenic. Unexpectedly, the virus became highly pathogenic in mice after a single lung-to-lung passage, resulting in 100% lethality with a mean death time (MDT) of 6.1 days postinfection (DPI). Moreover, the pathogenicity gradually increased after subsequent in vivo passages with an MDT of 5.2 and 4.2 DPI after the second and third passage, respectively. Our molecular analysis revealed that two amino acid changes in the polymerase complex (a glutamate-to-lysine substitution at position 627 of PB2 and a threonine-to-isoleucine substitution at position 97 of PA) were associated with the increased pathogenicity; the PB2 E627K mutation was responsible for the initial virulence conversion (0 to 100% lethality), while the PA T97I mutation acted as an accessory for the increased virulence.
- 29 June 2017
- Published by Springer Nature in Archives of Virology
- Vol. 162 (10) , 3017-3024
Rapid virulence shift of an H5N2 avian influenza virus during a single passage in mice
Influenza A viruses must undergo adaptation to acquire virulence in new host species. In mouse models, host adaptation for virulence is generally performed through 5 to 20 lung-to-lung passages. However, highly pathogenic avian influenza viruses (e.g., H5N1 and H7N7 subtypes) have been observed to acquire virulence in mice after only a few in vivo passages. In this study, a low-pathogenic avian influenza H5N2 virus, A/Aquatic Bird/Korea/CN2/2009, which was a prevalent subtype in South Korea in 2009, was serially passaged in mice to evaluate its potential to become highly pathogenic. Unexpectedly, the virus became highly pathogenic in mice after a single lung-to-lung passage, resulting in 100% lethality with a mean death time (MDT) of 6.1 days postinfection (DPI). Moreover, the pathogenicity gradually increased after subsequent in vivo passages with an MDT of 5.2 and 4.2 DPI after the second and third passage, respectively. Our molecular analysis revealed that two amino acid changes in the polymerase complex (a glutamate-to-lysine substitution at position 627 of PB2 and a threonine-to-isoleucine substitution at position 97 of PA) were associated with the increased pathogenicity; the PB2 E627K mutation was responsible for the initial virulence conversion (0 to 100% lethality), while the PA T97I mutation acted as an accessory for the increased virulence.